Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A W Hermans

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|August 24, 2017
[A rare cause of insufficiency fractures]M A W Hermans, P L A van Daele
The Netherlands Journal of Medicine|March 9, 2018
Nonsteroidal anti-inflammatory drug hypersensitivity: not always an allergy!M A W Hermans, R Otten, A F Karim, et al.
Emergency Medicine Journal : EMJ|April 23, 2011
The value of the Mortality in Emergency Department Sepsis (MEDS) score, C reactive protein and lactate in predicting 28-day mortality of sepsis in a Dutch emergency departmentM A W Hermans, P Leffers, L M Jansen, et al.
Endocrinology, Diabetes & Metabolism Case Reports|May 20, 2014
Two patients with a neuroendocrine tumour of the small intestine and paraneoplastic myasthenia gravisM A W Hermans, B M L Stelten, H R Haak, et al.
The Netherlands Journal of Medicine|October 23, 2020
HLH caused by an HSV-2 infection: a case report and review of the literatureE M Jongbloed, M A W Hermans, M Wabbijn, et al.
Hematology (Amsterdam, Netherlands)|May 11, 2017
Routine abdominal ultrasonography has limited value in the care for patients with indolent systemic mastocytosisC L de Mol, M A W Hermans, R Gerth van Wijk, et al.
Allergy|March 24, 2018
Low frequency of acetyl salicylic acid hypersensitivity in mastocytosis: The results of a double-blind, placebo-controlled challenge studyM A W Hermans, S Q A van der Vet, P M van Hagen, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 28, 2016
[Systemic mastocytosis: a heterogeneous disease]M A W Hermans, M Verburg, J A M van Laar, et al.
BMC Immunology|July 3, 2025
Impact of switching from the originator adalimumab to a biosimilar: a retrospective cohort studyW H A van Poecke, N E F Hooi, T K Mossel, et al.
Frontiers in Medicine|August 28, 2020
Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade<sup>®</sup> to Remsima<sup>®</sup>? An Observational StudyLaixi Xue, K van Bilsen, M W J Schreurs, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|August 24, 2017
[A rare cause of insufficiency fractures]M A W Hermans, P L A van Daele
The Netherlands Journal of Medicine|March 9, 2018
Nonsteroidal anti-inflammatory drug hypersensitivity: not always an allergy!M A W Hermans, R Otten, A F Karim, et al.
Emergency Medicine Journal : EMJ|April 23, 2011
The value of the Mortality in Emergency Department Sepsis (MEDS) score, C reactive protein and lactate in predicting 28-day mortality of sepsis in a Dutch emergency departmentM A W Hermans, P Leffers, L M Jansen, et al.
Endocrinology, Diabetes & Metabolism Case Reports|May 20, 2014
Two patients with a neuroendocrine tumour of the small intestine and paraneoplastic myasthenia gravisM A W Hermans, B M L Stelten, H R Haak, et al.
The Netherlands Journal of Medicine|October 23, 2020
HLH caused by an HSV-2 infection: a case report and review of the literatureE M Jongbloed, M A W Hermans, M Wabbijn, et al.
Hematology (Amsterdam, Netherlands)|May 11, 2017
Routine abdominal ultrasonography has limited value in the care for patients with indolent systemic mastocytosisC L de Mol, M A W Hermans, R Gerth van Wijk, et al.
Allergy|March 24, 2018
Low frequency of acetyl salicylic acid hypersensitivity in mastocytosis: The results of a double-blind, placebo-controlled challenge studyM A W Hermans, S Q A van der Vet, P M van Hagen, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 28, 2016
[Systemic mastocytosis: a heterogeneous disease]M A W Hermans, M Verburg, J A M van Laar, et al.
BMC Immunology|July 3, 2025
Impact of switching from the originator adalimumab to a biosimilar: a retrospective cohort studyW H A van Poecke, N E F Hooi, T K Mossel, et al.
Frontiers in Medicine|August 28, 2020
Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade<sup>®</sup> to Remsima<sup>®</sup>? An Observational StudyLaixi Xue, K van Bilsen, M W J Schreurs, et al.
Pageof 1